1.Interpretation of Imaging Diagnosis in the Multidisciplinary Experts Consensus on Diagnosis and Treatment of Precancerous Lesions of Hepatocellular Carcinoma
Fukun SHI ; Lan ZHANG ; Qian XU ; Jiameng SI ; Shengxiang RAO
Chinese Journal of Medical Imaging 2025;33(9):900-905
In recent years,the incidence and mortality rates of hepatocellular carcinoma in China have gradually become close to each other,reflecting persistent limitations in current diagnostic and therapeutic strategies.Given the close association between hepatocellular carcinoma development and the progression of precancerous lesions,the expert panel released the first edition of the Multidisciplinary Experts Consensus on Diagnosis and Treatment of Precancerous Lesions of Hepatocellular Carcinoma in 2020 and updated it in 2023,aiming to advance early-intervention strategies and improve overall patient survival rates.This article provides an in-depth interpretation of the key imaging diagnostic points outlined in the consensus,aiming to offer radiologists at all levels with a robust reference for early identification and diagnosis of hepatocellular carcinoma precancerous lesions,thereby facilitating critical support for timely patient intervention and treatment.
3.Emphasizing Prognosis in Hepatocellular Carcinoma:Adoption and Promotion of A Standardized Terminology System of Imaging
Qian XU ; Jiameng SI ; Lan ZHANG ; Shengxiang RAO
Chinese Journal of Medical Imaging 2025;33(3):233-237
As a globally prevalent malignancy with high morbidity and mortality rates,hepatocellular carcinoma has demonstrated significant potential in prognostic prediction and therapeutic evaluation through its imaging manifestations.This article focuses on the potential correlations between current imaging characteristics of hepatocellular carcinoma and its prognosis,emphasizing the importance of adopting and promoting a standardized imaging terminology system.It illustrates specific examples of imaging features associated with prognosis,reviews recent research hotspots and advancements in hepatocellular carcinoma prognosis.The aim is to offer precise prognostication,diagnosis and treatment strategies for patients with hepatocellular carcinoma.
4.Emphasizing Prognosis in Hepatocellular Carcinoma:Adoption and Promotion of A Standardized Terminology System of Imaging
Qian XU ; Jiameng SI ; Lan ZHANG ; Shengxiang RAO
Chinese Journal of Medical Imaging 2025;33(3):233-237
As a globally prevalent malignancy with high morbidity and mortality rates,hepatocellular carcinoma has demonstrated significant potential in prognostic prediction and therapeutic evaluation through its imaging manifestations.This article focuses on the potential correlations between current imaging characteristics of hepatocellular carcinoma and its prognosis,emphasizing the importance of adopting and promoting a standardized imaging terminology system.It illustrates specific examples of imaging features associated with prognosis,reviews recent research hotspots and advancements in hepatocellular carcinoma prognosis.The aim is to offer precise prognostication,diagnosis and treatment strategies for patients with hepatocellular carcinoma.
5.Interpretation of Imaging Diagnosis in the Multidisciplinary Experts Consensus on Diagnosis and Treatment of Precancerous Lesions of Hepatocellular Carcinoma
Fukun SHI ; Lan ZHANG ; Qian XU ; Jiameng SI ; Shengxiang RAO
Chinese Journal of Medical Imaging 2025;33(9):900-905
In recent years,the incidence and mortality rates of hepatocellular carcinoma in China have gradually become close to each other,reflecting persistent limitations in current diagnostic and therapeutic strategies.Given the close association between hepatocellular carcinoma development and the progression of precancerous lesions,the expert panel released the first edition of the Multidisciplinary Experts Consensus on Diagnosis and Treatment of Precancerous Lesions of Hepatocellular Carcinoma in 2020 and updated it in 2023,aiming to advance early-intervention strategies and improve overall patient survival rates.This article provides an in-depth interpretation of the key imaging diagnostic points outlined in the consensus,aiming to offer radiologists at all levels with a robust reference for early identification and diagnosis of hepatocellular carcinoma precancerous lesions,thereby facilitating critical support for timely patient intervention and treatment.
6.Effect of limiting value of subfield number on dosimetry of intensity-modulated radiotherapeutic plan for left-breast radical mastectomy
Ying LIU ; Huiling ZHANG ; Ping YANG ; Lan RAO
Chongqing Medicine 2024;53(8):1204-1208,1213
Objective To investigate the effect of the limiting value of subfield number on the dosime-try of intensity-modulated radiotherapy (IMRT) plan for left-breast radical mastectomy in order to seek the optimal limiting value of subfield number.Methods The clinical data of 30 patients with left-breast radical mastectomy in this hospital from March 1,2022 to March 31,2023 were retrospectively analyzed.All patients used the Oncentra 4.3 planning system to design 5 kinds of IMRT plans,and the limiting values of subfield number were 15,25,35,45 and 55 respectively (all IMRT plans were named according to the subfield number limiting value,the other optimization parameters and objective function were the same),planning target vol-ume (PTV) dosimetric parameters,organ at risk (OAR) receiving dosage and monitor units were statistically analyzed and compared.Results The PTV D2% (F=104.439,P<0.05),D98% (F=20.748,P<0.05),Dmean (F=89.578,P<0.05),homogeneity index (HI,F=101.794,P<0.05) and conformity index (CI,F=26.453,P<0.05) among different subfields number limiting values of IMRT had statistical differences,the left side humeral head V50 (F=76.991,P<0.05) had significant difference and the other OAR had no signifi-cant difference (P>0.05).The PTV D2%,D98%,Dmean,CI and HI values of plan35 were significantly superior to those of plan15 and plan25,and the differences were statistically significant (P<0.05).Compared with plan35,there were no statistically significant difference in PTV D98% and CI of plan45 and plan55 (P>0.05),while the PTV D2%,Dmean and HI were lower,and the difference was statistically significant (P<0.05).The V50 of left humeral head in plan15 and plan25 were too high to meet the clinical request.The plan35,plan45 and plan55 could protect the OAR well,moreover there were no significant difference in the receiving dosage of the OAR (P>0.05).The monitor units of plan35 was lower than that of plan45 and plan55,and the difference was statistically significant (P<0.05).Conclusion When the limiting value of subfield number is 35,the dose distribution of PTV and OAR receiving dosage meet the clinical dosimetric requirements,meanwhile the monitor units is lower,which can be used as a reference value for the IMPT plan design for left-breast cancer radical mastecto-my.
7.Interpretation of Updates for Imaging Diagnosis in Guidelines for the Diagnosis and Treatment of Primary Liver Cancer(2024 Edition)--Focusing on Imaging Diagnosis of Subcentimeter Hepatocellular Carcinoma
Chinese Journal of Medical Imaging 2024;32(6):529-532
Since the publication of guidelines for diagnosis and treatment of primary liver cancer by National Health Commission of the People's Republic of China in 2017,which were updated in 2019 and 2022.The new version of the guidelines(2024 edition)has been published,which aims to early diagnosis,treatment and improvement of survival rate for patients with hepatocellular carcinoma.Imaging is essential for early diagnosis of hepatocellular carcinoma and the new guidelines feature major changes in the imaging techniques for early diagnosis of subcentimeter hepatocellular carcinoma(diameter≤1.0 cm),which were interpretated in this article.
8.Comparison of Guidelines for Diagnosis and Treatment of Primary Liver Cancer(2024 Edition)with KLCA-NCC Guidelines(2022 Edition)and JSH Guidelines(2021 Edition)in Imaging Diagnosis:Integrating Strengths and Embracing Inclusivity
Junjie SHU ; Jiacheng ZHANG ; Lan ZHANG ; Wentao WANG ; Shengxiang RAO
Chinese Journal of Medical Imaging 2024;32(7):641-646
The incidence and mortality rates of primary liver cancer remain very high,posing a serious threat to the global public health.In Asia,the guidelines from the Korean Liver Cancer Association-National Cancer Center,the Japan Society of Hepatology,and the Chinese Guidelines for Diagnosis and Treatment of Primary Liver Cancer(2024 edition)have significant influence and provide important guidance for the diagnosis and treatment of primary liver cancer.These guidelines,based on their own national condition,background,evidence and clinical practice,exhibit both commonalities and divergences in the imaging diagnosis of liver cancer.This study aims to provide a more comprehensive and scientific reference for clinicians by comparing the specific contents of three guidelines regarding screening,surveillance,imaging diagnosis and staging of liver cancer,thereby promoting the standardized diagnosis and treatment of clinical practice in the primary liver cancer.
9.Establishment and evaluation of intestinal barrier dysfunction model in colonoids with irritable bowel syndrome
Kehan RAO ; Yongyin XU ; Zhao LAN ; Kai ZHAN ; Huan ZHENG ; Shumin QIN ; Shaogang HUANG ; Haomeng WU
Chinese Journal of Pathophysiology 2024;40(8):1559-1568
AIM:To establish and evaluate a colonoids model of intestinal barrier dysfunction with irritable bowel syndrome(IBS).METHODS:The colonic recess of 20~22 g male C57BL/6 mice were isolated and cultured in ma-trix glue to proliferate and differentiate into 3D hollow spheres with colonic epithelioid structure.The following experi-ments were carried out:(1)Colonoids and colonic tissues of mice were detected by immunofluorescence to identify colo-noids.(2)Fluorescein isothiocyanate dextran 4(FD4)evaluated the epithelial barrier function of colonoids.(3)To ex-plore the changes in the epithelial barrier of colonoids induced by interferon-γ(IFN-γ)at different concentrations and time points.FD4 and HE staining were used to evaluate the barrier function.RT-qPCR was used to detect the mRNA expres-sion of occludin and zonula occludens-1(ZO-1)in tight junctions of colonoids.Immunofluorescence was used to detect the distribution and localization of occludin and ZO-1 proteins.RESULTS:(1)The expression of EdU proliferation and in-testinal epithelial cell lineage markers in colonoids was consistent with that in mouse colonic tissues.(2)In the control group,FD4 did not infiltrate the colonoids lumen,but FD4 significantly infiltrated the colonoids lumen induced by ethyl-ene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid(EGTA).(3)From 18 h,the IFN-γ at 60,100,200 and 240 ng/mL could significantly infiltrate into the cavity of colonoids(0.033,0.032,0.042 and 0.001),and the barri-er injury of colonoids could be seen by HE staining.After 18 h,all concentrations of IFN-γ could significantly decrease the mRNA expression of occludin and ZO-1,and the fluorescence of occludin and ZO-1 decreased significantly(P<0.05).CONCLUSION:(1)The cultured organoids are colonoids with complete epithelial barrier.(2)IFN-γ could in-duce the decrease of the transcriptional levels of occludin and ZO-1 in the tight junction of colonoids,the decrease of the expression of corresponding proteins,and the change of localization and distribution,thus increasing the epithelial perme-ability of colonoids.This model is highly consistent with the pathophysiological state of IBS colonic mucosal barrier dys-function,which provides a new tool and method for studying the direction of colonic mucosal barrier dysfunction in IBS.
10.Research progress in pathogenesis and traditional Chinese medicines treatment of ischemic stroke-related headache.
Yu-Meng PENG ; Jun-Qi WANG ; Ying-Lu BAI ; Yan WANG ; Rao FU ; Yi-Yu LIU ; Zhi-Yong LI ; Xiu-Lan HUANG
China Journal of Chinese Materia Medica 2023;48(16):4261-4274
Headache is a common clinical complication of ischemic stroke. As a precursor of stroke, headache occurs repeatedly in the convalescent period of ischemic stroke, leading to secondary stroke and seriously hindering patients' rehabilitation. Currently, it is believed that the pathogenesis of ischemic stroke-related headache is associated with the abnormal release of vasoactive substances, high platelet aggregation, and stimulation of intracranial pain-sensitive structures. The active ingredients in traditional Chinese medicines(TCM) with the effects of activating blood to resolve stasis and clearing heat to release exterior can protect brain tissue and relieve headache by reducing the release of inflammatory cytokines, alleviating antioxidant stress, inhibiting neuronal apoptosis and so on. This paper introduces the research progress in the potential mechanism and TCM treatment of ischemic stroke-related headache, aiming to provide reference for further research and drug development of this complication.
Humans
;
Ischemic Stroke/drug therapy*
;
Brain Ischemia/drug therapy*
;
Medicine, Chinese Traditional
;
Stroke/drug therapy*
;
Headache/drug therapy*
;
Drugs, Chinese Herbal/therapeutic use*

Result Analysis
Print
Save
E-mail